This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

🍽️ allantoin non-drug

AI Engines For more Details: Perplexity  Kagi Labs  You 

  1. Skin Moisturization: Allantoin helps to hydrate and moisturize the skin by increasing water content in the outermost layer of the skin, known as the stratum corneum. It forms a protective barrier on the skin's surface, preventing moisture loss and keeping the skin soft, smooth, and supple.

  2. Wound Healing: Allantoin promotes wound healing and tissue regeneration by stimulating cell proliferation and collagen synthesis. It accelerates the shedding of dead skin cells and promotes the growth of new, healthy skin tissue, leading to faster wound closure and reduced scarring.

  3. Anti-inflammatory Effects: Allantoin has anti-inflammatory properties that help calm and soothe irritated or inflamed skin. It can help alleviate redness, itching, and discomfort associated with various skin conditions, such as eczema, dermatitis, psoriasis, and sunburn.

  4. Exfoliation: Allantoin acts as a gentle exfoliant, helping to remove dead skin cells and unclog pores, which can improve skin texture and reduce the appearance of blemishes, blackheads, and acne. It promotes smoother, clearer skin and enhances the effectiveness of other skincare ingredients.

  5. Scar Reduction: Allantoin is often included in scar treatment products, such as gels and creams, to help minimize the appearance of scars and stretch marks. It helps to soften and flatten scar tissue, reduce redness and discoloration, and improve overall skin texture and tone.

  6. Sunburn Relief: Allantoin has cooling and soothing properties that can provide relief from sunburn and other forms of skin irritation caused by excessive sun exposure. It helps to hydrate and nourish the skin, reducing inflammation and promoting healing.

  7. Foot Care: Allantoin is commonly used in foot creams and balms for the treatment of dry, cracked heels and calluses. It softens rough skin, helps to reduce callus buildup, and promotes smoother, healthier-looking feet.

  8. Diaper Rash Relief: Allantoin is gentle enough for use on delicate baby skin and is often included in diaper rash creams and ointments to soothe and protect irritated skin in the diaper area.

;

Check for interactions on Supp.AI   |   📚 PubMed Citations

Data Contradictions — Limits of Certainity

Impacted of allantoin non-drug On Probiotics

Rank Probiotic Impact
species Escherichia coli Reduces
species Faecalibacterium prausnitzii Reduces
species Lacticaseibacillus paracasei Reduces

Bacteria Impacted by allantoin non-drug

We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.

🧙?

📓 Direct Citations 👪👶 Indirect Citations Taxonomy Rank Effect
0 1 Escherichia genus Decreases
0 1 Lachnospira genus Decreases
0 1 Shigella genus Decreases
0 1 Ruminococcus genus Decreases
0 1 Clostridioides genus Decreases
0 1 Bacteroides genus Decreases
0 1 Eggerthella genus Decreases
0 1 Lacticaseibacillus genus Decreases
0 1 Coprococcus genus Decreases
0 1 Fusobacterium genus Decreases
0 1 Escherichia coli O1:K1:H7 no rank Decreases
0 1 Escherichia coli O139:H1 no rank Decreases
0 1 Escherichia coli O141:H4 no rank Decreases
0 1 Escherichia coli O145:H34 no rank Decreases
0 1 Escherichia coli O15:H12 no rank Decreases
0 1 Escherichia coli O155:H21 no rank Decreases
0 1 Escherichia coli O158:H23 no rank Decreases
0 1 Escherichia coli O16:H48 no rank Decreases
0 1 Escherichia coli O170:H18 no rank Decreases
0 1 Escherichia coli O18ac:H14 no rank Decreases
0 1 Escherichia coli O19:H7 no rank Decreases
0 1 Escherichia coli O2:K1:H4 no rank Decreases
0 1 Escherichia coli O2:K1:H5 no rank Decreases
0 1 Escherichia coli O2:K1:H7 no rank Decreases
0 1 Escherichia coli O20:H12 no rank Decreases
0 1 Escherichia coli O25:H16 no rank Decreases
0 1 Escherichia coli O55:H7 no rank Decreases
0 1 Escherichia coli O68:H12 no rank Decreases
0 1 Escherichia coli O7:H15 no rank Decreases
0 1 Escherichia coli O78:H51 no rank Decreases
0 1 Escherichia coli O80:H26 no rank Decreases
0 1 Escherichia coli O84:H7 no rank Decreases
0 1 Escherichia coli O85:H1 no rank Decreases
0 1 Escherichia coli O103 serogroup Decreases
0 1 Escherichia coli O111 serogroup Decreases
0 1 Escherichia coli O119 serogroup Decreases
0 1 Escherichia coli O121 serogroup Decreases
0 1 Escherichia coli O145 serogroup Decreases
0 1 Escherichia coli O155 serogroup Decreases
0 1 Escherichia coli O157 serogroup Decreases
0 1 Escherichia coli O177 serogroup Decreases
0 1 Escherichia coli O26 serogroup Decreases
0 1 Escherichia coli O3 serogroup Decreases
0 1 Escherichia coli O43 serogroup Decreases
0 1 Escherichia coli O5 serogroup Decreases
0 1 Escherichia coli O78 serogroup Decreases
0 1 Escherichia coli O86 serogroup Decreases
0 1 Escherichia coli O91 serogroup Decreases
0 1 Escherichia coli H20 serotype Decreases
0 1 Escherichia coli O1:H42 serotype Decreases
0 1 Escherichia coli O1:HNT serotype Decreases
0 1 Escherichia coli O10:H32 serotype Decreases
0 1 Escherichia coli O10:K5(L):H4 serotype Decreases
0 1 Escherichia coli O100:H21 serotype Decreases
0 1 Escherichia coli O103:H11 serotype Decreases
0 1 Escherichia coli O103:H2 serotype Decreases
0 1 Escherichia coli O103:H25 serotype Decreases
0 1 Escherichia coli O104:H21 serotype Decreases
0 1 Escherichia coli O104:H4 serotype Decreases
0 1 Escherichia coli O111:H- serotype Decreases
0 1 Escherichia coli O111:H11 serotype Decreases
0 1 Escherichia coli O111:H8 serotype Decreases
0 1 Escherichia coli O111:NM serotype Decreases
0 1 Escherichia coli O112ab:H8 serotype Decreases
0 1 Escherichia coli O112ac:H19 serotype Decreases
0 1 Escherichia coli O113:H21 serotype Decreases
0 1 Escherichia coli O114:H49 serotype Decreases
0 1 Escherichia coli O118:H16 serotype Decreases
0 1 Escherichia coli O121:H19 serotype Decreases
0 1 Escherichia coli O121:H7 serotype Decreases
0 1 Escherichia coli O123:H11 serotype Decreases
0 1 Escherichia coli O125ac:K+:H10 serotype Decreases
0 1 Escherichia coli O126:H45 serotype Decreases
0 1 Escherichia coli O127:H27 serotype Decreases
0 1 Escherichia coli O127:H6 serotype Decreases
0 1 Escherichia coli O128:H2 serotype Decreases
0 1 Escherichia coli O128ac:H12 serotype Decreases
0 1 Escherichia coli O139:H28 serotype Decreases
0 1 Escherichia coli O145:H25 serotype Decreases
0 1 Escherichia coli O145:H28 serotype Decreases
0 1 Escherichia coli O145:NM serotype Decreases
0 1 Escherichia coli O146:H21 serotype Decreases
0 1 Escherichia coli O15:H18 serotype Decreases
0 1 Escherichia coli O150:H6 serotype Decreases
0 1 Escherichia coli O152:H23 serotype Decreases
0 1 Escherichia coli O153:H2 serotype Decreases
0 1 Escherichia coli O156:H25 serotype Decreases
0 1 Escherichia coli O157:H- serotype Decreases
0 1 Escherichia coli O157:H43 serotype Decreases
0 1 Escherichia coli O157:H7 serotype Decreases
0 1 Escherichia coli O157:NM serotype Decreases
0 1 Escherichia coli O16:H6 serotype Decreases
0 1 Escherichia coli O165:H25 serotype Decreases
0 1 Escherichia coli O167:H26 serotype Decreases
0 1 Escherichia coli O174:H2 serotype Decreases
0 1 Escherichia coli O174:H21 serotype Decreases
0 1 Escherichia coli O174:H8 serotype Decreases
0 1 Escherichia coli O176:H45 serotype Decreases
0 1 Escherichia coli O177:NM serotype Decreases
0 1 Escherichia coli O2:H6 serotype Decreases
0 1 Escherichia coli O2:K2:H1 serotype Decreases
0 1 Escherichia coli O25:H1 serotype Decreases
0 1 Escherichia coli O25:NM serotype Decreases
0 1 Escherichia coli O26:H1 serotype Decreases
0 1 Escherichia coli O26:H11 serotype Decreases
0 1 Escherichia coli O28ac:NM serotype Decreases
0 1 Escherichia coli O29:H4 serotype Decreases
0 1 Escherichia coli O32:H37 serotype Decreases
0 1 Escherichia coli O39:NM serotype Decreases
0 1 Escherichia coli O44:H18 serotype Decreases
0 1 Escherichia coli O45:H2 serotype Decreases
0 1 Escherichia coli O6:H16 serotype Decreases
0 1 Escherichia coli O6:H16:CFA/II serotype Decreases
0 1 Escherichia coli O6:K2:H1 serotype Decreases
0 1 Escherichia coli O69:H11 serotype Decreases
0 1 Escherichia coli O7:H4 serotype Decreases
0 1 Escherichia coli O7:K1 serotype Decreases
0 1 Escherichia coli O78:H12 serotype Decreases
0 1 Escherichia coli O78:H4 serotype Decreases
0 1 Escherichia coli O79:H7 serotype Decreases
0 1 Escherichia coli O8:H8 serotype Decreases
0 1 Escherichia coli O81:NM serotype Decreases
0 1 Escherichia coli O83:H1 serotype Decreases
0 1 Escherichia coli O86:H34 serotype Decreases
0 1 Escherichia coli O89m:H10 serotype Decreases
0 1 Escherichia coli O89m:H9 serotype Decreases
0 1 Escherichia coli O9:H10 serotype Decreases
0 1 Escherichia coli O91:H14 serotype Decreases
0 1 Escherichia coli O91:NM serotype Decreases
0 1 Escherichia coli O99:H6 serotype Decreases
0 1 Escherichia coli ONT:H33 serotype Decreases
1 0 Escherichia coli species Decreases
1 0 Lachnospira eligens species Decreases
1 0 Ruminococcus bromii species Decreases
0 1 Shigella dysenteriae species Decreases
1 0 Clostridioides difficile species Decreases
0 1 Shigella flexneri species Decreases
0 1 Escherichia albertii species Decreases
1 0 Bacteroides xylanisolvens species Decreases
0 1 Escherichia fergusonii species Decreases
0 1 Shigella boydii species Decreases
0 1 Bacteroides luhongzhouii species Decreases
0 1 Shigella sonnei species Decreases
0 1 Escherichia marmotae species Decreases
0 1 Escherichia sp. E4742 species Decreases
0 1 Bacteroides sp. DH3716P species Decreases
1 0 Eggerthella lenta species Decreases
0 1 Bacteroides faecium species Decreases
0 1 Faecalibacterium prausnitzii species Decreases
0 1 Wujia chipingensis species Decreases
0 1 Simiaoa sunii species Decreases
0 1 Roseburia rectibacter species Decreases
1 0 Lacticaseibacillus paracasei species Decreases
1 0 Bacteroides fragilis species Decreases
1 0 Coprococcus comes species Decreases
1 0 Fusobacterium nucleatum species Decreases
0 1 Lacticaseibacillus paracasei subsp. paracasei subspecies Decreases
0 1 Lacticaseibacillus paracasei subsp. tolerans subspecies Decreases
0 1 Fusobacterium nucleatum subsp. nucleatum subspecies Decreases

Impact of allantoin non-drug on Conditions from US National Library of Medicine

A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.

We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive   X|increases + Y|decrease = Negative.

Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.

Condition Positive Impact Negative Impact Benefit Ratio Impact
ADHD 0.2 0.1 1
Allergic Rhinitis (Hay Fever) 0.4 0.6 -0.5
Allergies 1.8 0.7 1.57
Allergy to milk products 0.9 0.4 1.25
Alzheimer's disease 1 1.2 -0.2
Amyotrophic lateral sclerosis (ALS) Motor Neuron 1.4 0.8 0.75
Ankylosing spondylitis 1.6 0.6 1.67
Anorexia Nervosa 0.2 0.7 -2.5
Antiphospholipid syndrome (APS) 0.6 0.6
Asthma 1.3 0.2 5.5
Atherosclerosis 1.1 1.1
Atrial fibrillation 0.8 0.7 0.14
Autism 1.4 2.5 -0.79
Autoimmune Disease 0.6 0.6
Barrett esophagus cancer 0 0
benign prostatic hyperplasia 0.6 0.1 5
Biofilm 0.6 0.6
Bipolar Disorder 1 0.3 2.33
Brain Trauma 0.4 -0.4
Breast Cancer 0.6 0.6
Cancer (General) 0 0.1 0
Carcinoma 0.7 0.3 1.33
Celiac Disease 0.8 0.6 0.33
Cerebral Palsy 0.1 0.3 -2
Chronic Fatigue Syndrome 1.5 0.4 2.75
Chronic Kidney Disease 1 0.4 1.5
Chronic Lyme 0.3 0.1 2
Chronic Obstructive Pulmonary Disease (COPD) 0.6 0.3 1
Chronic Urticaria (Hives) 1 0.2 4
Coagulation / Micro clot triggering bacteria 1.2 0.2 5
Cognitive Function 0.3 0.3
Colorectal Cancer 1.9 0.7 1.71
Constipation 1.1 1.1
Coronary artery disease 1.4 0.3 3.67
COVID-19 1.6 1.4 0.14
Crohn's Disease 2.1 1.4 0.5
Cushing's Syndrome (hypercortisolism) 0.1 -0.1
cystic fibrosis 1 0.1 9
d-lactic acidosis (one form of brain fog) 0.6 0.6
deep vein thrombosis 1.3 0.3 3.33
Denture Wearers Oral Shifts 0 0
Depression 2.1 1.4 0.5
Eczema 0.7 0.1 6
Endometriosis 1.4 1.1 0.27
Eosinophilic Esophagitis 0 0
Epilepsy 1.5 0.1 14
erectile dysfunction 0.7 0.7
Fibromyalgia 0.1 0.2 -1
Functional constipation / chronic idiopathic constipation 1.8 0.4 3.5
gallstone disease (gsd) 1.2 0 0
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus 0.2 0.3 -0.5
Generalized anxiety disorder 1.4 0.1 13
Gout 0.5 0.3 0.67
Graves' disease 0.3 0.4 -0.33
Gulf War Syndrome 0 0.1 0
Halitosis 0.1 0.1
Hashimoto's thyroiditis 0.4 0.5 -0.25
Heart Failure 2.4 0.3 7
hemorrhagic stroke 0 0
Hidradenitis Suppurativa 0.4 0.4
High Histamine/low DAO 0.6 0.2 2
hypercholesterolemia (High Cholesterol) 0.6 0.6
hyperglycemia 1.2 0.2 5
hypertension (High Blood Pressure 1.1 1 0.1
Hypothyroidism 0.1 -0.1
Hypoxia 0.1 0.1
IgA nephropathy (IgAN) 0.3 0.6 -1
Inflammatory Bowel Disease 2.3 1.7 0.35
Insomnia 0.1 0.6 -5
Intelligence 0.7 0.1 6
Intracranial aneurysms 0.3 0 0
Irritable Bowel Syndrome 1.6 0.7 1.29
ischemic stroke 0.9 0.8 0.13
Liver Cirrhosis 1.4 0.9 0.56
Long COVID 0.9 1.6 -0.78
Low bone mineral density 0.3 -0.3
Lung Cancer 0.6 0.3 1
Lymphoma 0.6 0.6
Mast Cell Issues / mastitis 0.6 0.2 2
ME/CFS with IBS 0.2 -0.2
ME/CFS without IBS 0.2 0.1 1
Metabolic Syndrome 1.6 0.5 2.2
Mood Disorders 1.6 1.4 0.14
multiple chemical sensitivity [MCS] 0.1 -0.1
Multiple Sclerosis 1 1 0
Multiple system atrophy (MSA) 0.2 -0.2
myasthenia gravis 0.6 0.6
neuropathic pain 0.1 0.5 -4
Neuropathy (all types) 0.1 0.5 -4
neuropsychiatric disorders (PANDAS, PANS) 0.6 0.6
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic 1.8 0.7 1.57
NonCeliac Gluten Sensitivity 0.1 0.1 0
Obesity 1.9 1 0.9
obsessive-compulsive disorder 2.1 0.1 20
Osteoarthritis 0.4 0.4 0
Osteoporosis 0.9 0.1 8
pancreatic cancer 0 0
Parkinson's Disease 2.2 1.1 1
Polycystic ovary syndrome 1.4 0.6 1.33
Postural orthostatic tachycardia syndrome 0 0
primary biliary cholangitis 0 0
Primary sclerosing cholangitis 0.1 0.3 -2
Psoriasis 0.9 0.1 8
rheumatoid arthritis (RA),Spondyloarthritis (SpA) 1.6 0.3 4.33
Rosacea 0.2 0.1 1
Schizophrenia 0.7 0.6 0.17
scoliosis 0.6 0.8 -0.33
Sjögren syndrome 0.7 0.2 2.5
Sleep Apnea 0.5 0.2 1.5
Slow gastric motility / Gastroparesis 0.9 0.9
Small Intestinal Bacterial Overgrowth (SIBO) 0.7 0.7
Stress / posttraumatic stress disorder 0.9 0.3 2
Systemic Lupus Erythematosus 0.8 0.5 0.6
Tic Disorder 0.2 0.2
Tourette syndrome 0.1 -0.1
Type 1 Diabetes 1 0.7 0.43
Type 2 Diabetes 1.6 1.1 0.45
Ulcerative colitis 1.8 0.8 1.25
Unhealthy Ageing 0.6 0 0
Vitiligo 0.6 0 0

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]